Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alexandra Oltova"'
Autor:
Miroslav Boudny, Jana Zemanova, Prashant Khirsariya, Marek Borsky, Jan Verner, Jana Cerna, Alexandra Oltova, Vaclav Seda, Marek Mraz, Josef Jaros, Zuzana Jaskova, Michaela Spunarova, Yvona Brychtova, Karel Soucek, Stanislav Drapela, Marie Kasparkova, Jiri Mayer, Kamil Paruch, Martin Trbusek
Publikováno v:
Haematologica, Vol 104, Iss 12 (2019)
Introduction of small-molecule inhibitors of B-cell receptor signaling and BCL2 protein significantly improves therapeutic options in chronic lymphocytic leukemia. However, some patients suffer from adverse effects mandating treatment discontinuation
Externí odkaz:
https://doaj.org/article/e872ad7d936f40299c20d4bb02b9ef06
Autor:
Ester Mejstrikova, Jana Volejnikova, Eva Fronkova, Katerina Zdrahalova, Tomas Kalina, Jaroslav Sterba, Yahia Jabali, Vladimir Mihal, Bohumir Blazek, Zdena Cerna, Daniela Prochazkova, Jiri Hak, Zuzana Zemanova, Marie Jarosova, Alexandra Oltova, Petr Sedlacek, Jiri Schwarz, Jan Zuna, Jan Trka, Jan Stary, Ondrej Hrusak
Publikováno v:
Haematologica, Vol 95, Iss 6 (2010)
Background Mixed phenotype acute leukemia (MPAL) represents a diagnostic and therapeutic dilemma. The European Group for the Immunological Classification of Leukemias (EGIL) scoring system unambiguously defines MPAL expressing aberrant lineage marker
Externí odkaz:
https://doaj.org/article/00e3c2b1f9cb4fb2adcf9b49b33ebc86
Publikováno v:
American Journal of Hematology
Autor:
Michael, Doubek, Yvona, Brychtova, Anna, Panovska, Ludmila, Sebejova, Olga, Stehlikova, Jana, Chovancova, Jitka, Malcikova, Jana, Smardova, Karla, Plevova, Pavlina, Volfova, Martin, Trbusek, Marek, Mraz, Denisa, Bakesova, Jakub, Trizuljak, Marketa, Hadrabova, Petra, Obrtlikova, Josef, Karban, Lukas, Smolej, Alexandra, Oltova, Eva, Jelinkova, Sarka, Pospisilova, Jiri, Mayer
Publikováno v:
American Journal of Hematology. 90(5):417-421
The treatment of relapsed/refractory chronic lymphocytic leukemia (CLL) remains a challenging clinical issue. An important treatment option is the use of high-dose corticosteroids. The purpose of this clinical trial was to determine the efficacy and